RDD Pharma Ltd.
Records under this name other than patents RDD Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to RDD Pharma Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,849,114 | Oxymetazoline for the treatment of ano-rectal disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,686,040 | Method for treating anal pruritis and other perianal disorders Formerly held Lapsed on the fee record Ended Apr 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2026 | From the USPTO record |
| US 10,821,274 | Methods and devices for delivery of pharmaceutical agents within orifices of the body Lapsed on the fee record Ended Nov 3, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 3, 2024 | From the USPTO record |
| US 8,734,826 | Device and method for treating the anal sphincter Lapsed on the fee record Ended May 27, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 27, 2022 | From the USPTO record |
| US 8,715,706 | Methods and devices for delivery of pharmaceutical agents within orifices of the body Lapsed on the fee record Ended May 6, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2022 | From the USPTO record |
| US 9,937,136 | Methods for treating radiation induced gastrointestinal tract injury Lapsed on the fee record Ended Apr 10, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 10, 2022 | From the USPTO record |